New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.
As longtime cancer doctors with regulatory experience, Pi Health cofounders Geoff Kim and Bobby Reddy knew that completing clinical trials took far too long. There was the painfully slow process of signing up patients and after that a grueling slog through vast swamps of data to prepare voluminous regulatory filings–something that few hospitals…
Continue Reading
News Source: www.forbes.com

Leave a Reply